Traws Pharma, Inc. (TRAW) Earnings History
Net Loss15 years of earnings data (2011–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Traws Pharma, Inc. (TRAW) Earnings Overview
As of June 29, 2026, Traws Pharma, Inc. (TRAW) reported trailing twelve-month net income of -$24M, reflecting +102.3% year-over-year growth. The company earned $-2.25 per diluted share over the past four quarters, with a net profit margin of 328.7%.
Looking at the long-term picture, TRAW's historical earnings data spans multiple years. The company achieved its highest annual net income of $9M in fiscal 2025, representing a new all-time high.
Traws Pharma, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including VRTX ($4.34B net income, 32.7% margin), IMVT (-$506M net income), GILD ($9.22B net income, 28.9% margin), TRAW has outperformed on profitability metrics. Compare TRAW vs VRTX →
TRAW Earnings vs Peers
Earnings metrics vs comparable public companies
TRAW Historical Earnings Data (2011–2025)
15 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $9M | +116.8% | -$18M | $0.82 | 328.7% | -640.7% |
| 2024 | -$55M | -188.5% | -$49M | $-35.21 | -24192.0% | -21835.4% |
| 2023 | -$19M | +0.1% | -$20M | $-22.57 | -8384.1% | -8981.4% |
| 2022 | -$19M | -17.3% | -$20M | $-22.68 | -8391.2% | -8684.5% |
| 2021 | -$16M | +35.8% | -$16M | $-24.01 | -7151.8% | -7299.1% |
| 2020 | -$25M | -17.0% | -$25M | $-54.21 | -10890.5% | -10819.5% |
| 2019 | -$22M | -4.5% | -$22M | $-560.58 | -985.0% | -994.0% |
| 2018 | -$21M | +14.6% | -$23M | $-1870.69 | -1675.3% | -1895.9% |
| 2017 | -$24M | -22.5% | -$26M | $-15056.00 | -3061.2% | -3270.3% |
| 2016 | -$20M | +18.0% | -$24M | $-24975.00 | -354.6% | -427.4% |
| 2015 | -$24M | +62.3% | -$24M | $-59062.00 | -209.3% | -209.3% |
| 2014 | -$64M | +1.8% | -$64M | $-165375.00 | -7960.3% | -7968.0% |
| 2013 | -$65M | -91.5% | -$62M | $-344250.00 | -1364.7% | -1309.1% |
| 2012 | -$34M | -11.7% | -$22M | $-150187.00 | -73.3% | -48.2% |
| 2011 | -$30M | - | -$28M | $-134437.00 | -2038.6% | -1854.3% |
Download Data
Export TRAW earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
15+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TRAW — Frequently Asked Questions
Quick answers to the most common questions about buying TRAW stock.
What is TRAW earnings per share (EPS)?
TRAW trailing twelve-month (TTM) diluted EPS is $-2.25, reflecting +102.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2011 to 2025 is available in the table on this page.
What is Traws Pharma, Inc.'s net income?
Traws Pharma, Inc. (TRAW) trailing twelve-month net income is $-24M as of 2025. Earnings grew +102.3% year-over-year.
Is TRAW profitable?
TRAW is not currently profitable on a TTM basis, reporting a net loss of $-24M. Net margin is +328.7%. Investors should monitor for a return to profitability.
What is TRAW's earnings growth rate?
TRAW compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2011 to 2025.
What are TRAW's profit margins?
Traws Pharma, Inc. net profit margin is +328.7%, operating margin is -640.7%, and gross margin is +100.0%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is N/A.
Is TRAW growing earnings?
Yes, TRAW earnings are accelerating — EPS growth of +102.3% exceeds the 5-year CAGR of N/A. TTM net income reached $-24M. Earnings momentum is strengthening.
What was TRAW's best earnings year?
Traws Pharma, Inc.'s highest annual net income on record is $9M, achieved in fiscal year 2025. Earnings history on this page spans 2011 to 2025 and includes all annual and quarterly figures.
What were TRAW's earnings last quarter?
TRAW's most recent reported quarter was Q2 2026. Net income was $-7M with diluted EPS of $-0.53. For a full breakdown of all quarters, see the quarterly earnings table on this page.